NCT01824667

Brief Summary

The aim of the study is to evaluate the effects of a new food supplement which is currently available in the market, called Bimuno® (B-GOS), on gastrointestinal discomfort (e.g. bloating, abdominal pain/cramp and flatulence) in adults who often experience these symptoms but are otherwise healthy. About 400 volunteers will take part in this study, which will last 6 weeks (to include 4 weeks treatment and 2 weeks follow up period). Episodes of abdominal pain or discomfort (e.g. bloating, abdominal pain/cramp and flatulence), in the absence of diseases, are commonly associated with food or drug intake or with alterations of bowel habit and vary between individuals in frequency and severity. Some dietary ingredients are known to reduce these symptoms. We have used B-GOS previously in trials with healthy younger and older adults and we have observed a trend towards reducing abdominal bloating. However, the investigators have not tested B-GOS in healthy adults who often experience these symptoms and this is what we will investigate now.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
400

participants targeted

Target at P50-P75 for phase_3 healthy

Timeline
Completed

Started Feb 2013

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 1, 2013

Completed
24 days until next milestone

First Submitted

Initial submission to the registry

February 25, 2013

Completed
1 month until next milestone

First Posted

Study publicly available on registry

April 5, 2013

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2013

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2013

Completed
Last Updated

November 27, 2013

Status Verified

April 1, 2013

Enrollment Period

9 months

First QC Date

February 25, 2013

Last Update Submit

November 26, 2013

Conditions

Outcome Measures

Primary Outcomes (1)

  • To determine the effect of B-GOS on GI discomfort

    questionnaires

    Participants will be followed daily for 6 weeks

Secondary Outcomes (1)

  • To conduct an assessment of stools

    Participants will be followed daily for 6 weeks.

Other Outcomes (1)

  • To assess the effect of B-GOS on the quality of life and general well being.

    beginning and end of the study

Study Arms (2)

B-GOS

EXPERIMENTAL

2.75g daily for 4 weeks

Dietary Supplement: B-GOS

Maltodextrin

PLACEBO COMPARATOR

2.75g daily for 4 weeks

Dietary Supplement: Maltodextrin

Interventions

B-GOSDIETARY_SUPPLEMENT
Also known as: Bimuno
B-GOS
MaltodextrinDIETARY_SUPPLEMENT
Also known as: corn syrup
Maltodextrin

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Aged between 18 and 65 years old.
  • Presence of bloated feeling or experiencing abdominal fullness, with or without visible distention, often in the last 12 months.
  • Ability to communicate well with the investigator and to comply with the requirements of the entire study.
  • Volunteer has given written informed consent to participate and is willing to participate in the entire study.

You may not qualify if:

  • History or evidence of organic disease of the gastrointestinal tract; such as tumour, irritable bowel syndrome, etc., within the previous 5 years.
  • Undergone surgical resection of any part of the bowel.
  • History of malignancy within the previous 5 years (with exception of well-treated basal cell carcinoma or in situ cervical carcinoma).
  • Received antibiotics in the previous four weeks.
  • Consumed probiotic or prebiotic preparations on a regular basis (at least 3 times per week) in the last 2 weeks.
  • Former participation in another study involving prebiotic or probiotic preparations or investigational drugs within the previous one month, or intention to use such drugs during the course of the study.
  • Severe allergy or any history of severe abnormal drug reaction, drug or alcohol abuse.
  • Regular use of any medication with exception of hormonal replacement therapy and contraception.
  • Women who are pregnant or breast-feeding.
  • Fertile women not practicing a medically-approved method of contraception.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Research Insights Ltd

Oxford, OX11 9LH, United Kingdom

Location

MeSH Terms

Interventions

maltodextrinHigh Fructose Corn Syrup

Intervention Hierarchy (Ancestors)

Dietary SugarsDietary CarbohydratesCarbohydratesSugarsNutritive SweetenersSweetening AgentsFlavoring AgentsFood AdditivesFood IngredientsSpecialty Uses of ChemicalsChemical Actions and UsesFoodDiet, Food, and NutritionPhysiological PhenomenaFood and Beverages

Study Design

Study Type
interventional
Phase
phase 3
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 25, 2013

First Posted

April 5, 2013

Study Start

February 1, 2013

Primary Completion

November 1, 2013

Study Completion

November 1, 2013

Last Updated

November 27, 2013

Record last verified: 2013-04

Locations